Does LANADELUMAB-FLYO Cause Mobility decreased? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Mobility decreased have been filed in association with LANADELUMAB-FLYO. This represents 0.8% of all adverse event reports for LANADELUMAB-FLYO.
12
Reports of Mobility decreased with LANADELUMAB-FLYO
0.8%
of all LANADELUMAB-FLYO reports
0
Deaths
7
Hospitalizations
How Dangerous Is Mobility decreased From LANADELUMAB-FLYO?
Of the 12 reports, 7 (58.3%) required hospitalization, and 3 (25.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANADELUMAB-FLYO. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does LANADELUMAB-FLYO Cause?
Hereditary angioedema (794)
Product dose omission issue (177)
Inappropriate schedule of product administration (144)
Drug ineffective (137)
Headache (126)
Weight decreased (125)
Weight increased (120)
Injection site pain (119)
Product use issue (114)
Malaise (90)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which LANADELUMAB-FLYO Alternatives Have Lower Mobility decreased Risk?
LANADELUMAB-FLYO vs LANREOTIDE
LANADELUMAB-FLYO vs LANSOPRAZOLE
LANADELUMAB-FLYO vs LANTHANUM
LANADELUMAB-FLYO vs LANTUS
LANADELUMAB-FLYO vs LANTUS SOLOSTAR